Literature DB >> 35861870

Combined distal femoral osteotomy and tibial tuberosity distalization is effective in patients presenting with patellar instability and patellofemoral pain due to patella alta and femoral malalignment.

Julian Fluegel1, Felix Zimmermann2, Sebastian Gebhardt3, Danko Dan Milinkovic4, Peter Balcarek5,6.   

Abstract

INTRODUCTION: Patellar malalignment has been considered one of the major pathomechanical causes of patellofemoral instability and pain. The results have been reported after femoral varization/torsional osteotomy and tibial tuberosity distalization osteotomy (TTD-O). However, the combination of a femoral deformity (genu valgum/increased femur antetorsion) and patella alta remains underreported. Therefore, the aim of this study was to investigate the clinical outcomes of patients simultaneously treated by distal femoral osteotomy and TTD-O. The hypothesis was that restoration of patellofemoral (PF) alignment via the abovementioned osteotomies would achieve good patient-reported outcome measures.
MATERIALS AND METHODS: Between 2016 and 2019, a series of 25 knees in 20 patients were treated by a distal femoral osteotomy combined with a TTD-O aiming to correct patellofemoral malalignment consisting of genu valgum and/or increased femur antetorsion and patella alta. Six patients were lost to follow-up, and one patient refused to participate. Thus, 17 knees in 13 patients (male/female 1/12; age 27.4 ± 5.4 years) were included and comprised the study group for this investigation. Patients were evaluated after a mean of 3.1 ± 0.9 years postoperatively. The Kujala anterior knee pain scale and the PF-subscale of the Knee Osteoarthritis and Outcome score (KOOS-PF) were used to assess patients' reported outcome measures from pre- to postoperatively.
RESULTS: The mean amount of torsional correction, valgus correction, and tibial tuberosity distalization averaged 14° (10°-18°), 5.2° (3.8°-8°), and 9 mm (6°-15 mm), respectively. The Kujala score increased by an average of 24.18 points from a mean of 66.6 ± 18.3 points (34-93 points) preoperatively to 90.8 ± 14.2 points (44-100 points) postoperatively (95% CI - 33.0 to - 15.3; p < 0.0001). The KOOS-PF score increased by an average of 33.7 points from a mean of 49.5 ± 24.5 points (9.1-88.6 points) preoperatively to 83.2 ± 21.6 points (15.9 -100 points) postoperatively (95% CI - 47.5 to - 19.9; p < 0.0001).
CONCLUSION: The findings of this study indicate that the combination of a distal femoral osteotomy and a tibial tuberosity distalization osteotomy is effective in patients presenting with patellar instability and patellofemoral pain due to patella alta and femoral malalignment.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Femur antetorsion; Genu valgum; Patella alta; Patellar instability; Patellofemoral pain; Tibial tuberosity distalization

Year:  2022        PMID: 35861870     DOI: 10.1007/s00402-022-04541-y

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   2.928


  29 in total

1.  Torsional osteotomies of the femur.

Authors:  Jörg Dickschas; Jörg Harrer; Benoit Reuter; Judith Schwitulla; Wolf Strecker
Journal:  J Orthop Res       Date:  2014-11-17       Impact factor: 3.494

2.  Torsional osteotomies of the tibia in patellofemoral dysbalance.

Authors:  Jörg Dickschas; Aliki Tassika; Christoph Lutter; Jörg Harrer; Wolf Strecker
Journal:  Arch Orthop Trauma Surg       Date:  2016-12-21       Impact factor: 3.067

3.  The effect of trochlear dysplasia on patellofemoral biomechanics: a cadaveric study with simulated trochlear deformities.

Authors:  Annemieke Van Haver; Karel De Roo; Matthieu De Beule; Luc Labey; Patrick De Baets; David Dejour; Tom Claessens; Peter Verdonk
Journal:  Am J Sports Med       Date:  2015-03-04       Impact factor: 6.202

4.  Factors of patellar instability: an anatomic radiographic study.

Authors:  H Dejour; G Walch; L Nove-Josserand; C Guier
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

5.  Revision surgery for failed medial patellofemoral ligament reconstruction results in better disease-specific outcome scores when performed for recurrent instability than for patellofemoral pain or limited range of motion.

Authors:  Felix Zimmermann; Danko D Milinkovic; Juliane Börtlein; Peter Balcarek
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-09-07       Impact factor: 4.342

6.  Patellofemoral dysbalance and genua valga: outcome after femoral varisation osteotomies.

Authors:  Jörg Dickschas; Felix Ferner; Christoph Lutter; Kolja Gelse; Jörg Harrer; Wolf Strecker
Journal:  Arch Orthop Trauma Surg       Date:  2017-10-27       Impact factor: 3.067

7.  Evidence-based framework for a pathomechanical model of patellofemoral pain: 2017 patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester, UK: part 3.

Authors:  Christopher M Powers; Erik Witvrouw; Irene S Davis; Kay M Crossley
Journal:  Br J Sports Med       Date:  2017-11-06       Impact factor: 13.800

8.  The reversed dynamic patellar apprehension test mimics anatomical complexity in lateral patellar instability.

Authors:  Felix Zimmermann; Michael C Liebensteiner; Peter Balcarek
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-10-06       Impact factor: 4.342

9.  Objective assessment of patellar maltracking with 3 T dynamic magnetic resonance imaging: feasibility of a robust and reliable measuring technique.

Authors:  Jannik Frings; Tobias Dust; Matthias Krause; Malte Ohlmeier; Karl-Heinz Frosch; Gerhard Adam; Malte Warncke; Kai-Jonathan Maas; Frank Oliver Henes
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

10.  Outcomes After Deepening Trochleoplasty and Concomitant Realignment in Patients With Severe Trochlear Dysplasia With Chronic Patellofemoral Pain: Results at 2-Year Follow-up.

Authors:  Felix Zimmermann; Danko Dan Milinkovic; Peter Balcarek
Journal:  Orthop J Sports Med       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.